Novel alkylating agent, ureidomustine exhibit pre-clinical efficacy in B-cell lymphoma with minimal dose-limiting myelotoxicity Meeting Abstract


Authors: Lopes, E. C.; Shieh, J. H.; Ambati, S.; Tsann-Long, S.; Correa, F.; Peguero, E.; Moore, M. A. S.
Abstract Title: Novel alkylating agent, ureidomustine exhibit pre-clinical efficacy in B-cell lymphoma with minimal dose-limiting myelotoxicity
Meeting Title: 57th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 126
Issue: 23
Meeting Dates: 2015 Dec 5-8
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2015-12-03
Language: English
ACCESSION: WOS:000368019005034
PROVIDER: wos
Notes: Meeting Abstract: 1556 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos
MSK Authors
  1. Srikanth Reddy Ambati
    27 Ambati
  2. Jae-Hung Shieh
    69 Shieh
  3. Malcolm A S Moore
    427 Moore
  4. Elizabeth Peguero
    11 Peguero
  5. Fabian Mauricio Correa
    7 Correa